Select Page
Expert Discussion - ViroChannel

It has become an increasing challenge to attend medical and scientific conferences and remain abreast of clinically-relevant advances and their impact on daily clinical practice. With a Canadian panel perspective, this program delivers key highlights from three important Fall conferences.

Expert Review 2011: EACS, HIV and Aging, AASLD (Liver Meeting)

with Mark A. Wainberg, PhD, Dr. Frederic Crouzat, Alice Tseng, B.Sc.Phm. and Dr. Stephan D. Shafran

HIGHLIGHTS

13th European AIDS Conference

  • STARTMRK 192
  • VIKING 24
  • ATL to CTL
  • TDR in MSM

HIV and Aging

  • Premature age-related comorbidities
  • CVD and dementia
  • Falls: prevalence and risk factors
  • Aging challenges

The Liver Meeting (AASLD)

  • Study 110
  • COMMAND-1
  • PSI-7977 PROTON
  • PSI-7977 ELECTRON
  • DAA Combination Therapy
  • ZENITH

This activity is supported by an educational grant from:

EACS2011

PARTICIPANTS

Mark A. Wainberg, PhD

Mark A. Wainberg, PhD

Moderator

Director
McGill AIDS Centre
Professor of Medicine
McGill University
Montréal, Quebec

Frederic Crouzat, CCFP

Frederic Crouzat, CCFP

Speaker

HIV Specialist
Maple Leaf Medical Clinic
Toronto, Ontario

Alice Tseng, B.Sc.Phm., Pharm.D., FCSHP, AAHIVP

Alice Tseng, B.Sc.Phm., Pharm.D., FCSHP, AAHIVP

Speaker

HIV Pharmacotherapy Specialist
Toronto General Hospital
Assistant Professor
Leslie Dan Faculty of Pharmacy
University of Toronto
Toronto, Ontario

Stephan D. Shafran, MD, FRCPC, FACP

Stephan D. Shafran, MD, FRCPC, FACP

Speaker

Professor
Division of Infectious Diseases
University of Alberta
Edmonton, Canada

COMPLETE PROGRAM

Only Logged in users can see the full program

Focus on EACS 2011

.
.
.

Focus on HIV and Aging 2011

.
.
.

Focus on AASLD 2011

DISCLOSURE

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.


Mark A. Wainberg, PhD currently has no financial interests/relationships or affiliations in relation to this activity.

Alice Tseng, B.Sc.Phm., Pharm.D., FCSHP, AAHIVP has a financial interest/relationship or affiliation:
(2009-2011) Unrestricted educational grants: Merck, Janssen, ViiV, Abbott; lectures: Abbott, Merck, ViiV; conference sponsorships: Janssen, Merck, Abbott.

Frederic Crouzat, CCFP has a financial interest/relationship or affiliation:
Abbott, Boehringer Ingelheim, BMS, Gilead, GlaxoSmithKline, Lilly, Merck, Pfizer, Solvay, Tibotec, ViiV.

Stephan D. Shafran, MD, FRCPC, FACP has a financial interest/relationship or affiliation:
Abbott, BMS, Boehringer Ingelheim, Gilead, GSK, Janssen, Pfizer, Roche, Vertex.


Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.